Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
Titel:
Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma
Auteur:
Parker, Joseph M Oh, Chad K LaForce, Craig Miller, S David Pearlman, David S Le, Chenxiong Robbie, Gabriel J White, Wendy I White, Barbara Molfino, Nestor A the MEDI-528 Clinical Trials Group